Related Experiment Video
Updated: Apr 15, 2026

Laminectomy for the Removal of Thoracic Ossification of the Ligamentum Flavum TOLF Using Ultrasonic and Conventional Osteotomes
Published on: April 21, 2023
Challenges in Diagnosis and Management of Coffin-Lowry Syndrome-Single-Center Experience
Ana Maria Chirilas1, Alexandru Cărămizaru2,3, Anca-Lelia Riza1,2
1Regional Centre of Medical Genetics Dolj, Emergency County Hospital Craiova, 200642 Craiova, Romania.
Insights
Coffin-Lowry syndrome (CLS), a rare genetic disorder, is caused by RPS6KA3 gene variants. Early molecular diagnosis and comprehensive genetic screening are crucial for effective management and individualized care.
Area of Science:
- Genetics
- Rare Diseases
- Molecular Biology
Background:
- Coffin-Lowry syndrome (CLS) is a rare X-linked genetic disorder.
- It is characterized by intellectual disability, distinct facial features, and skeletal abnormalities.
Purpose of the Study:
- To report clinical and genetic findings in 10 Coffin-Lowry syndrome cases.
- To emphasize the importance of molecular diagnosis in rare genetic disorders.
Main Methods:
- Clinical evaluation of 10 patients (8 males, 2 females).
- Genetic testing to identify variants in the RPS6KA3 gene.
Main Results:
- Ten de novo variants in the RPS6KA3 gene were identified.
- These included missense, nonsense, frameshift, and intronic region variants.
Conclusions:
- Molecular diagnosis is vital for Coffin-Lowry syndrome, especially with atypical presentations.
- Comprehensive genetic screening and individualized care are essential for managing CLS.
Abstract:
Background/Objectives: Coffin-Lowry syndrome (CLS) is a rare X-linked disease caused by pathogenic variants in the RPS6KA3 gene. It is generally characterized by syndromic intellectual disability and distinctive facial features, skeletal abnormalities, stimulus-induced drop attacks in males, and variable manifestations in females. Methods: We report clinical and genetic findings in a series of 10 cases, eight males and two females, evaluated at the Regional Centre of Medical Genetics Dolj-Emergency Clinical County Hospital Craiova. Results: Genetic testing identified 10 de novo variants in the RPS6KA3 gene consisting of six missense mutations, one nonsense variant, one frameshift, and two variants in non-coding or intronic regions. Case management requires multidisciplinary coordination and is limited to resources mostly available in reference centers. Conclusions: CLS highlights the importance of molecular diagnosis in rare genetic disorders, particularly when clinical features are subtle or atypical. These findings have practical implications for clinical management, suggesting the need for comprehensive genetic screening and individualized care approaches.
More Related Videos
11:53Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome
Published on: May 10, 2022
12:25C-arm-Free Simultaneous OLIF51 and Percutaneous Pedicle Screw Fixation in a Single Lateral Position
Published on: September 16, 2022
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Nephrotic Syndrome II : Assessment and Medical Management
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Mitral Stenosis III: Medical Management
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...